class-action-notice:-berger-montague-advises-tenax-therapeutics,-inc.-(tenx)-investors-to-inquire-about-a-securities-fraud-class-actionCLASS ACTION NOTICE: Berger Montague Advises Tenax Therapeutics, Inc. (TENX) Investors to Inquire About a Securities Fraud Class Action

Philadelphia, Pennsylvania–(Newsfile Corp. – November 4, 2026) – Berger Montague, a leading national plaintiffs’ law firm, announces a class action lawsuit against Tenax Therapeutics, Inc. (NASDAQ: TENX) (“Tenax” or the “Company”) on behalf of investors who purchased or otherwise acquired Tenax securities during the period from November 13, 2023 through August 7, 2026 (the “Class Period”). The deadline to apply for lead plaintiff is December 28, 2026.Q&AWhat is this lawsuit about?The…